Free Trial
NASDAQ:ZYBT

Zhengye Biotechnology (ZYBT) Stock Price, News & Analysis

Zhengye Biotechnology logo
$5.75 -0.01 (-0.17%)
As of 04:00 PM Eastern

About Zhengye Biotechnology Stock (NASDAQ:ZYBT)

Key Stats

Today's Range
$5.40
$5.77
50-Day Range
$5.16
$9.30
52-Week Range
$3.50
$14.30
Volume
8,287 shs
Average Volume
39,437 shs
Market Capitalization
$271.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ZYBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zhengye Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

ZYBT Stock News Headlines

Wall Street Zen Upgrades Zhengye Biotechnology (NASDAQ:ZYBT) to Hold
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
Zhengye Biotechnology Holding Ltd
See More Headlines

ZYBT Stock Analysis - Frequently Asked Questions

Zhengye Biotechnology's stock was trading at $4.86 at the beginning of 2025. Since then, ZYBT shares have increased by 18.3% and is now trading at $5.75.

Zhengye Biotechnology (ZYBT) raised $6 million in an initial public offering on Tuesday, January 7th 2025. The company issued 1,500,000 shares at a price of $4.00 per share. Kingswood Capital Partners served as the underwriter for the IPO.

Zhengye Biotechnology's lock-up period expired on Monday, July 7th. Zhengye Biotechnology had issued 1,500,000 shares in its public offering on January 7th. The total size of the offering was $6,000,000 based on an initial share price of $4.00. Shares of the company owned by company insiders and major shareholders are now eligible to be traded as a result of the expiration of the lock-up period.

Shares of ZYBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ZYBT
Previous Symbol
NASDAQ:ZYBT
CIK
1975641
Fax
N/A
Employees
278
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
1.31
Quick Ratio
0.88

Sales & Book Value

Annual Sales
$186.36 million
Price / Sales
1.46
Cash Flow
$0.11 per share
Price / Cash Flow
51.44
Book Value
$1.02 per share
Price / Book
5.64

Miscellaneous

Outstanding Shares
47,166,000
Free Float
N/A
Market Cap
$271.20 million
Optionable
N/A
Beta
N/A
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:ZYBT) was last updated on 8/5/2025 by MarketBeat.com Staff
From Our Partners